Exhaled Nitric Oxide Concentration in Children with Asthma and Allergic Rhinitis: Association with Atopy and Bronchial Hyperresponsiveness.
- Author:
Kyu Min NAH
1
;
Yang PARK
;
Eun Kyeong KANG
;
Hee KANG
;
Young Yull KOH
;
Sun Wha LEE
;
Domyung PAEK
Author Information
1. Department of Pediatrics, Seoul National University College of Medicine, Seoul, Korea. kohyy@plaza.snu.ac.kr
- Publication Type:Original Article
- Keywords:
Exhaled nitric oxide;
Asthma;
Allergic rhinitis;
Bronchial hyperresponsiveness;
Atopy
- MeSH:
Asthma*;
Child*;
Forced Expiratory Volume;
Humans;
Methacholine Chloride;
Nitric Oxide*;
Rhinitis*;
Skin Tests;
Spirometry
- From:Journal of the Korean Pediatric Society
2003;46(3):284-290
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
PURPOSE: A new airway inflammatory marker, exhaled nitric oxide(ENO) has been reported to correlate with bronchial hyperresponsiveness(BHR) and atopy. The purpose of this study was to analyze the relationship of ENO with BHR or atopy in patients with asthma and with allergic rhinitis. METHODS: The subjects consisted of 55 children with asthma, 17 with allergic rhinitis, and 14 healthy controls. The asthma group was subdivided into the atopic asthma group(n=37) and the nonatopic asthma group(n=18) and the allergic rhinitis group into BHR group(n=7) and non-BHR group(n=10). All were investigated with spirometry and measurements of ENO concentration. The correlations between ENO concentration and both methacholine PC20(provocative concentration causing a 20% decrease in forced expiratory volume in one second) and the number of allergen skin test positivity were analyzed. RESULTS: ENO concentrations of both asthma and allergic rhinitis groups were significantly greater than that of control(P<0.01). ENO concentration of atopic asthma was significantly greater than that of nonatopic asthma(P<0.01). In allergic rhinitis, ENO concentration did not differ according to the presence or absence of BHR(P=0.50). ENO concentrations correlated significantly with the number of skin test positivity(r=0.32, P=0.02) or methacholine PC20(r=-0.38, P<0.01) in asthma group, but not in the allergic rhinitis group(r=0.42, P=0.09; r=-0.06, P=0.83). CONCLUSION: In asthma patients, some pathogenetic mechanisms associated with atopy and BHR seem to influence ENO concentration. In allergic rhinitis patients, some factors other than BHR may be important in determining ENO concentration.
